Clinical trials
Hematologic Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
148 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 8 |
| 2019 | 5 |
| 2020 | 6 |
| 2021 | 20 |
| 2022 | 18 |
| 2023 | 20 |
| 2024 | 16 |
| 2025 | 18 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 45 |
| Recruiting | 43 |
| Completed | 27 |
| Not yet recruiting | 18 |
| Active, not recruiting | 8 |
| Terminated | 5 |
| Suspended | 1 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese PLA General Hospital | 8 |
| First Affiliated Hospital of Zhejiang University | 6 |
| Institute of Hematology & Blood Diseases Hospital, China | 5 |
| Nanfang Hospital, Southern Medical University | 5 |
| Ruijin Hospital | 5 |
| Zhejiang University | 5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 4 |
| Peking University People's Hospital | 4 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 4 |
| The First Affiliated Hospital of Soochow University | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 148 |
| Recurrence | 21 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 10 |
| Leukemia, Myeloid, Acute | 10 |
| Lymphoma | 10 |
| Multiple Myeloma | 10 |
| Lymphoma, Mantle-Cell | 8 |
| Neoplasms | 8 |
| Hematologic Diseases | 7 |
| Leukemia | 7 |
Trials
Showing 1 to 25 of 148. Each trial links to its page on Pharma Observatory.
48 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.